Dr. Ankur Bahl

Dr. Ankur Bahl

Brief Profile:

Dr. Ankur Bahl is a highly proficient cancer specialist with over 15 years of extensive experience in this domain. He graduated from Maulana Azad Medical College in Delhi, where he earned his MBBS, followed by an MD in Medicine. He completed his DM in Medical Oncology at the esteemed AIIMS New Delhi. Additionally, he has undertaken a course on Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance at the University of Oxford in the UK. Dr. Bahl possesses clinical expertise in Immunotherapy, targeted therapies in conjunction with Chemotherapy, Hormonal Therapy, as well as Supportive and Palliative Care.  

He is the principal author of the largest real-world Indian data on targeted therapy (Cetuximab) in Head & Neck cancer, Acute Myeloid Leukaemia Treatment, and Human Papillomavirus trends in the Indian population, among others. Furthermore, he is the founding leader of various innovative oncology educational platforms and networks, both internationally and nationally, which include evidence-based debates in oncology, live oncology tumor boards, master classes, and workshops in the field. Dr. Bahl has recently joined FMRI in Gurugram after serving as the Director of Medical Oncology and Hematology Oncology at Max Hospital in Saket. Prior to this, he was affiliated with prestigious organizations such as the Rajiv Gandhi Cancer Institute and Research Centre and Maulana Azad Medical College.  Dr. Ankur Bahl is a distinguished cancer specialist with more than 15 years of rich experience in this field. He is an alumnus of Maulana Azad Medical College in Delhi, where he completed his MBBS, followed by an MD in Medicine. He pursued his DM in Medical Oncology at the renowned AIIMS New Delhi. He has also finished a course on Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance at the University of Oxford in the UK. Dr. Bahl has clinical expertise in Immunotherapy, targeted therapies combined with Chemotherapy, Hormonal Therapy, and Supportive and Palliative Care.  He is the lead author of the largest real-world Indian data on targeted therapy (Cetuximab) in Head & Neck cancer, Acute Myeloid Leukaemia Treatment, and trends of Human Papillomavirus in the Indian population, among other topics.

He is also the founding leader of various innovative oncology educational platforms and networks, both internationally and nationally, which include evidence-based debates in oncology, live oncology tumor boards, master classes, and workshops in oncology. Dr. Bahl has recently joined FMRI in Gurugram after serving as the Director of Medical Oncology and Hematology Oncology at Max Hospital in Saket. Previously, he was associated with esteemed organizations such as the Rajiv Gandhi Cancer Institute and Research Centre and Maulana Azad Medical College.  Dr. Ankur Bahl is a highly accomplished cancer specialist with over 15 years of extensive experience in this area. He is an alumnus of Maulana Azad Medical College in Delhi, where he obtained his MBBS, followed by an MD in Medicine. He completed his DM in Medical Oncology at the prestigious AIIMS New Delhi. Additionally, he has completed a course on Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance at the University of Oxford in the UK. Dr. Bahl has clinical expertise in Immunotherapy, targeted therapies in combination with Chemotherapy, Hormonal Therapy, as well as Supportive and Palliative Care.  He is the lead author of the largest real-world Indian data on targeted therapy (Cetuximab) in Head & Neck cancer, Acute Myeloid Leukaemia Treatment, and trends of Human Papillomavirus in the Indian population, among other subjects.

He is also the founding leader of various innovative oncology educational platforms and networks, both internationally and nationally, which include evidence-based debates in oncology, live oncology tumor boards, master classes, and workshops in the field. Dr. Bahl has recently joined FMRI in Gurugram after serving as the Director of Medical Oncology and Hematology Oncology at Max Hospital in Saket. Prior to this, he was associated with prestigious institutions such as the Rajiv Gandhi Cancer Institute and Research Centre and Maulana Azad Medical College.

Work Experience:

• Fortis Memorial Research Institute, gurgaon, India (2021- Present)
• Max Super Specialty Hospital, Saket, New Delhi; Senior Consultant, Medical Oncology (2013–2021)
• DNB Fellow at RGCI & RC New Delhi's Department of Medical Oncology (2009)
• Senior resident in the medical department at Maulana Azad Medical College in New Delhi (2007-2009)

Education:

• MBBS, Moulana Azad Medical College/G B Pant Hospital, New Delhi, 2003
• MD - Medicine - Moulana Azad Medical College / G B Pant Hospital, New Delhi, 2007
• DM - All India Institute of Medical Sciences, New Delhi, 2012; Medical Oncology
• Course on pharmacovigilance, drug interactions, and adverse drug reactions at the University of Oxford in the United Kingdom

AWARDS & ACCOMPLISHMENTS

• Gold Medal (Dr. Rehan Gold Medal) for the top postgraduate student in internal medicine at Delhi University.
• Several publications in reputable books and international and national journals.
• Chief Author of the most extensive real-world Indian data set on human papillomavirus trends in Indian population, treatment for acute myeloid leukemia, and targeted therapy (cetuximab) in head and neck cancer, among other topics.
• Principal initiator of numerous cutting-edge national and international cancer education networks and platforms: Live oncology tumor boards, master seminars, and workshops; evidence-based oncology debates.
• Advisors to different R&D projects in biopharmaceutics.
• Professional guide for medical oncology fellows and students in different national and international locations.
• Professional guide for medical oncology fellows and students in different national and international locations.

MEMBERSHIPS & CERTIFICATIONS

• Global EGFR Advisory Network member
• ASCO (American Society of Clinical Oncology)
• ICON (Indian Cooperative Oncology Network)
• AACR (American Association of Cancer ReISMPO (India Society of Medical & Paediatric Oncology)search)
• ESMO (European Society of Medical Oncology)
• Core Committee member of Immuno-oncology network in India
• ISMPO (India Society of Medical & Paediatric Oncology)